Medical Condition News

RSS

ACC Latin America 2026 brings together experts to examine the latest cardiovascular science

The American College of Cardiology (ACC) and the Colombian Society of Cardiology and Cardiovascular Surgery will host the ACC Latin America 2026 conference on September 17-19 in Medellín, Colombia.

9 Sep 2026

New project explores financial impact of chronic kidney disease

A new research project launched by Kidney Wales and Aston University will explore how living with chronic kidney disease affects people's financial wellbeing.

9 Sep 2026

Updated COVID-19 vaccines protect adults with autoimmune rheumatic conditions

In an Arthritis & Rheumatology analysis of data on 60,980 US adults with autoimmune rheumatic conditions who developed COVID-19 between December 2020 and August 2024, those who received booster or updated (2023-2024) COVID-19 vaccines were less likely to be hospitalized for COVID-19 compared to those who received only the initial series vaccines or who were unvaccinated.

9 Sep 2026

New integrated framework advances precision surgery for liver cancer

Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally.

9 Sep 2026

New AI model forecasts glucose changes in type 1 diabetes patients

Diabetes is one of the most common chronic diseases, affecting around 66 million adults in Europe - a figure projected to rise to more than 72 million by 2050.

9 Sep 2026

Is stroke risk higher after a cancer diagnosis?

New research indicates that people with invasive cancer face an elevated risk of experiencing a stroke, especially in the first few months after diagnosis and especially if they have certain types of cancer.

9 Sep 2026

UCLA researchers develop scalable TCR therapy for solid tumors

T cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision. It's similar to another treatment, CAR T-cell therapy, but with one key difference: CAR T-cell therapy can only spot proteins that naturally appear outside of a cancer cell.

8 Sep 2026

Cognitive behavioral therapy for insomnia may slow biological aging in older adults

A new UCLA Health study found that treatment of insomnia using cognitive behavioral therapy slowed the pace of biological aging in older adults.

8 Sep 2026

Stevia tastes sweet, but does your body react as if sugar is coming?

In a randomized, double-blind crossover study, researchers tested stevia alone and with glucose in adults with normal weight, overweight, or type 2 diabetes to assess acute effects on blood glucose, insulin, gut hormones, appetite, and subsequent food intake. Stevia produced no significant changes in the measured glycemic or hormonal responses compared with water and did not significantly modify responses to glucose, while appetite and subsequent energy intake were also generally unchanged.

8 Sep 2026

Study finds weak evidence for post-hospital alcohol use disorder treatment

A systematic review by researchers at the University of Colorado Anschutz and Yale University found limited evidence that hospital-based interventions can help people with alcohol use disorder connect with outpatient treatment after they leave the hospital.

8 Sep 2026

Helicobacter pylori exposure linked to one in five cases of bowel cancer

Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of bowel cancer worldwide, suggests an exploratory risk attribution study, published in the open access journal eGastroenterology.

8 Sep 2026

Laptop heat exposure causes rare skin rash and discoloration

Balancing an electronic device on bare skin risks disfiguration, doctors warn in the online journal BMJ Case Reports, after treating a child with skin discoloration and a 'fishnet' rash -hallmarks of erythema ab igne-caused by repeated exposure to the low grade heat from a laptop.

8 Sep 2026

COVID-19 linked to lower subsequent risk of type 1 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D).

8 Sep 2026

Integrated mental health care could transform Canada's primary care

As Prime Minister Mark Carney prepares to host the inaugural Canada Investment Summit in Toronto this September, a new review co-led by researchers at UBC argues that the country is leaving one of its largest economic and health-care system opportunities untouched: the integration of psychological care into primary care.

8 Sep 2026

Researchers use an experimental drug to reverse the effects of systemic sclerosis

Investigators at Cedars-Sinai Health Sciences University used an experimental drug to reverse the effects of systemic sclerosis, a serious autoimmune disease. The study, conducted in a laboratory, was published in JCI Insight.

8 Sep 2026

New approach repairs airway barrier defects in cystic fibrosis

A UNIGE team has succeeded in restoring the defective respiratory protective barrier in people with this rare genetic disease.

8 Sep 2026

Retinal immune cell gateway may unlock targeted uveitis treatments

As part of an effort to understand the molecules and mechanisms that regulate transendothelial migration in different vascular beds of the body, researchers focused on the blood vessels of the retina, part of the blood-brain barrier.

8 Sep 2026

High-dose flu vaccine protects older adults with lung disease

The risk of being hospitalized for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

8 Sep 2026

New biologic therapy significantly reduces COPD flare-ups in trials

Two international clinical trials led in part by researchers at the University of Pittsburgh School of Medicine found that the investigational biologic therapy tozorakimab significantly reduced chronic obstructive pulmonary disease (COPD) flare-ups among patients already receiving standard treatment for the disease compared to patients only receiving standard treatment.

8 Sep 2026

New drug forces aggressive leukemia cells to die from stress

Pushing the accelerator and the brake at the same time is rarely a good idea. But researchers at the University of Gothenburg are using this approach to treat leukemia.

8 Sep 2026